Amniotic tissue transplantation as a trial of treatment in some lysosomal storage diseases
- Cite this article as:
- Tylki-Szymańska, A., Maciejko, D., Kidawa, M. et al. J Inherit Metab Dis (1985) 8: 101. doi:10.1007/BF01819289
- 38 Downloads
This communication reports the clinical and biochemical results in six patients: four with mucopolysaccharidosis, one with GM1 gangliosidosis (Morquio B) and one with I-cell disease, who were treated by amniotic tissue transplantation. The sole evident clinical result was the diminishing of corneal clouding in three cases. A slight increase of beta-galactosidase activity in one patient's plasma was observed. The time of improvement was about 2 months after the transplantation and was transitory.